Comparison of Two Treatments in Intermediate and High-risk Acute Promyelocytic Leukemia (APL) Patients to Assess Efficacy in 1st Hematological Complete Remission and Molecular Remission
Clinical trial NCT00962767 · COMPLETED
Trial details
- NCT number
- NCT00962767
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-05-01
- Primary completion
- 2007-12-01
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.